Literature DB >> 26684306

Focal seizure associated with human parvovirus B19 infection in a non-encephalopathic child.

Debopam Samanta1, Erin Willis2.   

Abstract

BACKGROUND: The incidence of acute symptomatic (at the time of documented brain insult) seizures and single unprovoked seizures are 29-39 and 23-61 per 100 000 per year, respectively. After stabilization of the patient, finding the etiology of the seizure is of paramount importance. A careful history and physical examination may allow a diagnosis without need for further evaluation.
METHODS: In the literature, severe central nervous system involvement has been reported from human parvovirus B19 infection. We reported a previously healthy 7-year-old girl who presented after an episode of focal seizure. She was afebrile and didn't have any focal neurological abnormalities. She had erythematous malar rash along with reticulating pattern of rash over her both upper extremities.
RESULTS: Parvovirus infection was suspected due to the characteristic erythematous malar rash. Serum human parvovirus B19 DNA polymerase chain reaction was positive which was consistent with acute parvovirus infection. Further confirmation of current infection was done with Sandwich enzyme immunoassays showing positive anti-B19 IgM Index (>1.1). IgG index was equivocal (0.9-1.1).
CONCLUSIONS: We report an extremely rare presentation of non-febrile seizure from acute parvovirus infection in a child without encephalopathy who had an excellent recovery. Timely diagnosis can provide counselling regarding future seizure recurrence risk, curtail expenditure from expensive diagnostic work up and provide additional recommendations about potential risks to a pregnant caregiver.

Entities:  

Keywords:  erythema infectiosum; human parvovirus B19; nonfebrile seizure

Mesh:

Year:  2015        PMID: 26684306     DOI: 10.1007/s12519-015-0060-0

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  10 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Refractory status epilepticus owing to human parvovirus B19 encephalitis in a child.

Authors:  Ilknur Erol; Füsun Alehan; Kizbes Yalçin
Journal:  J Child Neurol       Date:  2006-09       Impact factor: 1.987

3.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

4.  Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American Academy of Neurology, The Child Neurology Society, and The American Epilepsy Society.

Authors:  D Hirtz; S Ashwal; A Berg; D Bettis; C Camfield; P Camfield; P Crumrine; R Elterman; S Schneider; S Shinnar
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

Review 5.  Neurologic manifestations associated with parvovirus B19 infection.

Authors:  Miltiadis Douvoyiannis; Nathan Litman; David L Goldman
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

6.  Gianotti-Crosti syndrome: clinical, serologic, and therapeutic data from nine children.

Authors:  K Boeck; M Mempel; T Schmidt; D Abeck
Journal:  Cutis       Date:  1998-12

Review 7.  Neurological manifestations of human parvovirus B19 infection.

Authors:  Faraj Barah; Pamela J Vallely; Graham M Cleator; Jonathan R Kerr
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

8.  Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults.

Authors:  Valentia Mage; Dan Lipsker; Sébastien Barbarot; Didier Bessis; Olivier Chosidow; Pascal Del Giudice; Sélim Aractingi; Jérôme Avouac; Claire Bernier; Vincent Descamps; Nicolas Dupin
Journal:  J Am Acad Dermatol       Date:  2014-04-14       Impact factor: 11.527

Review 9.  First seizure definitions and worldwide incidence and mortality.

Authors:  W Allen Hauser; Ettore Beghi
Journal:  Epilepsia       Date:  2008       Impact factor: 5.864

10.  Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection.

Authors:  David Hsu; Christy Sandborg; Jin S Hahn
Journal:  J Child Neurol       Date:  2004-04       Impact factor: 1.987

  10 in total
  2 in total

1.  Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19.

Authors:  Libo Zhang; Rongrong Pang; Xiang Xue; Jingjing Bao; Sheng Ye; Yudong Dai; Yishan Zheng; Qiang Fu; Zhiliang Hu; Yongxiang Yi
Journal:  Aging (Albany NY)       Date:  2020-04-22       Impact factor: 5.682

2.  Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.

Authors:  Xiaoyong Zhang; Suwen Lu; Hui Li; Yi Wang; Zhen Lu; Zhihong Liu; Qingtao Lai; Yali Ji; Xuan Huang; Yongyin Li; Jian Sun; Yingsong Wu; Xiaoning Xu; Jinlin Hou
Journal:  Virol Sin       Date:  2020-12-22       Impact factor: 4.327

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.